Yahoo Finance

Degenerative Disc Disease Market Forecast - 2032; NSAIDs, Opioids, and others are major revenue generators

Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The ...
BioWorld

Discgenics’ cell therapy on phase III track for disc degeneration

Phase I/II data of IDCT (rebonuputemcel), a cell therapy in development for chronic and progressive lumbar degenerative disc disease and one that has both regenerative medicine advanced therapy and ...
abc27

Peer-Reviewed Article Reporting DiscGenics' Cell Therapy Phase I/II Study Results Receives International Journal of Spine Surgery Best Paper Award

SALT LAKE CITY, April 9, 2025 /PRNewswire/ -- DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for ...
WKRG

DiscGenics Announces the International Journal of Spine Surgery Has Published Results from an FDA-Approved Study of an Allogeneic Disc Progenitor Cell Therapy for the Treatment ...

SALT LAKE CITY, July 9, 2024 /PRNewswire/ -- DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for ...